What's next, pharmatorials?

PositionNo Comment

The New England Journal of Medicine is loosening its conflict-of-interest rules so it can publish evaluations of new drugs by researchers with financial ties to the pharmaceutical manufacturers. "Editors concede there is risk that the objectivity of authors may be compromised, but say that otherwise...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT